Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial

Following the tremendous efforts of the principal investigator, Dr Joost Daemen (cardiologist at Thoraxcenter at the Erasmus University Medical Center, Rotterdam, The Netherlands), over 35 participating centers and ECRI (sponsor of the trial), the patient enrollment has concluded. Following the tremendous efforts of the principal investigator,DrJoost Daemen (cardiologist at Thoraxcenter at theErasmus UniversityMedical Center,Rotterdam, The Netherlands ), over 35 participating...

Netherlands, 18/06/2024 (informazione.news - comunicati stampa - salute e benessere)

Following the tremendous efforts of the principal investigator, (cardiologist at Thoraxcenter at the Erasmus University Medical Center, Rotterdam, The Netherlands ), over 35 participating centers and ECRI (sponsor of the trial), the patient enrollment has concluded.

Additionally,

and Siemens Healthineers (Erlangen, Germany ). The study is (European Cardiovascular Research Institute, Rotterdam-the Netherlands ). Cardialysis ( Rotterdam, The Netherlands ) is responsible for trial services including trial management and Core Laboratory activities.

 is a world leader in analysis and visualization of cardiovascular images. In Maastricht ( The Netherlands ), it hosts the global sales for the CAAS and 3mensio product lines.

PMI and 3mensio Medical Imaging , leader in the biomedical equipment sector.  More information about PMI is available at www.piemedicalimaging.com 

Photo - https://mma.prnewswire.com/media/2438118/CAAS_vFFR.jpg
Logo -  https://mma.prnewswire.com/media/2438117/PMI_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/pie-medical-imaging-announces-enrollment-completion-of-the-fastiii-clinical-trial-302172284.html